Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Hepatitis B treatment stories

Oct 20, 2026

FDA approves GSK's hepatitis B drug Hibsago

The FDA approved GSK's hepatitis B drug Hibsago, allowing patients with the liver infection to maintain viral control after stopping long-term treatment. The approval offers a new treatment option for chronic hepatitis B patients.

Oct 20, 2026·2 sources
00
May 28, 2026

GSK's Experimental Hepatitis B Drug Achieves Functional Cure in Nearly 1 in 5 Patients in Late-Stage Trials

GSK reported that its experimental chronic hepatitis B drug helped nearly one in five patients achieve a functional cure in late-stage studies, vastly outpacing current treatments and raising hopes for a finite treatment course as an alternative to lifelong therapy.

May 28, 2026·2 sources
00

Top claims

  • ▪Prescribing warnings for Hibsago include risks of deteriorating kidney function, serious inflammatory adverse reactions such as vasculitis, and complications from improper injection
  • ▪Patients using Hibsago require regular blood tests during therapy to monitor for hepatic flares, reduced platelet counts, and kidney function risks
  • ▪Hibsago has secured regulatory approval in Japan and is under regulatory review by health authorities in China and Europe

Subtopics

Chronic disease management2Drug Approval and Clinical Trials2Drug Policy, Pricing & Approval2Antiviral therapy1Clinical evaluation1Clinical Trial Design & Evaluation1Drug development1FDA drug approval1FDA regulatory approval1Infectious disease1Infectious Disease and Outbreaks1Outbreak monitoring & surveillance1Pharmaceutical Industry1

Related timelines

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories

Strait of Hormuz blockage

148 stories